{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T23:30:31Z","timestamp":1792971031039,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T00:00:00Z","timestamp":1546905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T00:00:00Z","timestamp":1546905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The single and\/or combination use of immune checkpoint blockade therapies in human infectious diseases and cancer are rapidly expanding. Despite early efforts, substantial uncertainty remains about the safety and efficacy of immune checkpoint blockade in some populations. Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and T-cell immunoglobulin mucin-3 (Tim-3) are the major targetable co-inhibitory receptors on T cells. Here we showed that in animal studies, treatment with either CTLA-4- or Tim-3-blocking antibody caused greater susceptibility to fetal loss with altered cytokine profiles by decidual CD4<jats:sup>+<\/jats:sup>T (dCD4<jats:sup>+<\/jats:sup>T) cells. CTLA-4 and Tim-3 pathways appeared to play key roles in maintaining maternal-fetal tolerance by regulating the function of dCD4<jats:sup>+<\/jats:sup>T cells. In addition, the abnormality in number and functionality of dCTLA-4<jats:sup>+<\/jats:sup>Tim-3<jats:sup>+<\/jats:sup>CD4<jats:sup>+<\/jats:sup>T cells was associated with miscarriage. These findings underscored the important roles of the CTLA-4 and Tim-3 pathways in regulating dCD4<jats:sup>+<\/jats:sup>T cells function and maintaining normal pregnancy. Our study also emphasized the importance of careful consideration of reproductive safety when choosing immune checkpoint blockade therapies in real world clinical care.<\/jats:p>","DOI":"10.1038\/s41419-018-1251-0","type":"journal-article","created":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T17:17:15Z","timestamp":1546967835000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Blockade of CTLA-4 and Tim-3 pathways induces fetal loss with altered cytokine profiles by decidual CD4+T cells"],"prefix":"10.1038","volume":"10","author":[{"given":"Songcun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunqin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengdie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfeng","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingxing","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dajin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meirong","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,8]]},"reference":[{"key":"1251_CR1","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1053\/j.gastro.2017.06.017","volume":"153","author":"G Zhou","year":"2017","unstructured":"Zhou, G. et al. Antibodies against immune checkpoint molecules restore functions of tumor-infiltrating T cells in hepatocellular carcinomas. Gastroenterology 153, 1107\u20131119 (2017).","journal-title":"Gastroenterology"},{"key":"1251_CR2","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1056\/NEJMoa1003466","volume":"363","author":"FS Hodi","year":"2010","unstructured":"Hodi, F. S. et al. Improved survival with ipilimumab in patients with metastatic melanoma. N. Engl. J. Med. 363, 711\u2013723 (2010).","journal-title":"N. Engl. J. Med."},{"key":"1251_CR3","doi-asserted-by":"crossref","unstructured":"Sasso, E. et al. Massive parallel screening of phage libraries for the generation of repertoires of human immunomodulatory monoclonal antibodies. Mabs-Austin, 10, 1060\u20131072 (2018).","DOI":"10.1080\/19420862.2018.1496772"},{"issue":"Suppl 1","key":"1251_CR4","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1159\/000481245","volume":"93","author":"M Kudo","year":"2017","unstructured":"Kudo, M. Immuno-Oncology in Hepatocellular Carcinoma: 2017 Update. Oncol.-Basel 93(Suppl 1), 147\u2013159 (2017).","journal-title":"Oncol.-Basel"},{"key":"1251_CR5","doi-asserted-by":"crossref","unstructured":"KD, M. & Le Gros-G. The role of CTLA-4 in the regulation of T cell immune responses. Immunol. Cell Biol.,\u00a077,1-10 (1999).","DOI":"10.1046\/j.1440-1711.1999.00795.x"},{"key":"1251_CR6","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1038\/ni1271","volume":"6","author":"C Zhu","year":"2005","unstructured":"Zhu, C. et al. The Tim-3 ligand galectin-9 negatively regulates T helper type 1immunity. Nat. Immunol. 6, 1245\u20131252 (2005).","journal-title":"Nat. Immunol."},{"key":"1251_CR7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1093\/humupd\/dml048","volume":"13","author":"C Ferretti","year":"2007","unstructured":"Ferretti, C., Bruni, L., Dangles-Marie, V., Pecking, A. P. & Bellet, D. Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblasts. Hum. Reprod. Update 13, 121\u2013141 (2007).","journal-title":"Hum. Reprod. Update"},{"key":"1251_CR8","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/nm.3160","volume":"19","author":"PC Arck","year":"2013","unstructured":"Arck, P. C. & Hecher, K. Fetomaternal immune cross-talk and its consequences for maternal and offspring\u2019s health. Nat. Med 19, 548\u2013556 (2013).","journal-title":"Nat. Med"},{"key":"1251_CR9","doi-asserted-by":"publisher","first-page":"682","DOI":"10.3389\/fimmu.2017.00682","volume":"8","author":"W Zeng","year":"2017","unstructured":"Zeng, W. et al. Distinct transcriptional and alternative splicing signatures of decidual CD4(+) T cells in early human pregnancy. Front Immunol. 8, 682 (2017).","journal-title":"Front Immunol."},{"key":"1251_CR10","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.imlet.2004.01.011","volume":"92","author":"G Chaouat","year":"2004","unstructured":"Chaouat, G. et al. Reproductive immunology 2003: reassessing the Th1\/Th2 paradigm? Immunol. Lett. 92, 207\u2013214 (2004).","journal-title":"Immunol. Lett."},{"key":"1251_CR11","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1093\/infdis\/jiu265","volume":"210","author":"Y Liu","year":"2014","unstructured":"Liu, Y. et al. Adoptive transfer of Treg cells counters adverse effects of Toxoplasma gondii infection on pregnancy. J. Infect. Dis. 210, 1435\u20131443 (2014).","journal-title":"J. Infect. Dis."},{"key":"1251_CR12","first-page":"1767","volume":"9","author":"B Comin-Anduix","year":"2016","unstructured":"Comin-Anduix, B., Escuin-Ordinas, H. & Ibarrondo, F. J. Tremelimumab: research and clinical development. Onco Targets Ther. 9, 1767\u20131776 (2016).","journal-title":"Onco Targets Ther."},{"key":"1251_CR13","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13045-018-0582-8","volume":"11","author":"JA Marin-Acevedo","year":"2018","unstructured":"Marin-Acevedo, J. A. et al. Next generation of immune checkpoint therapy in cancer: new developments and challenges. J. Hematol. Oncol. 11, 39 (2018).","journal-title":"J. Hematol. Oncol."},{"key":"1251_CR14","doi-asserted-by":"publisher","first-page":"7219","DOI":"10.1073\/pnas.1507977112","volume":"112","author":"T Tilburgs","year":"2015","unstructured":"Tilburgs, T. et al. Human HLA-G+ extravillous trophoblasts: immune-activating cells that interact with decidual leukocytes. Proc. Natl Acad. Sci. USA 112, 7219\u20137224 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1251_CR15","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1053\/plac.1999.0496","volume":"21","author":"A King","year":"2000","unstructured":"King, A. et al. Surface expression of HLA-C antigen by human extravillous trophoblast. Placenta 21, 376\u2013387 (2000).","journal-title":"Placenta"},{"key":"1251_CR16","doi-asserted-by":"publisher","first-page":"4546","DOI":"10.1172\/JCI43127","volume":"120","author":"RH McMahan","year":"2010","unstructured":"McMahan, R. H. et al. Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity. J. Clin. Invest. 120, 4546\u20134557 (2010).","journal-title":"J. Clin. Invest"},{"key":"1251_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.imlet.2014.06.013","volume":"162","author":"C La Rocca","year":"2014","unstructured":"La Rocca, C., Carbone, F., Longobardi, S. & Matarese, G. The immunology of pregnancy: regulatory T cells control maternal immune tolerance toward the fetus. Immunol. Lett. 162, 41\u201348 (2014).","journal-title":"Immunol. Lett."},{"key":"1251_CR18","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/ni.2035","volume":"12","author":"EJ Wherry","year":"2011","unstructured":"Wherry, E. J. T cell exhaustion. Nat. Immunol. 12, 492\u2013499 (2011).","journal-title":"Nat. Immunol."},{"key":"1251_CR19","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1146\/annurev.immunol.25.022106.141609","volume":"25","author":"GA Rabinovich","year":"2007","unstructured":"Rabinovich, G. A., Gabrilovich, D. & Sotomayor, E. M. Immunosuppressive strategies that are mediated by tumor cells. Annu. Rev. Immunol. 25, 267\u2013296 (2007).","journal-title":"Annu. Rev. Immunol."},{"key":"1251_CR20","doi-asserted-by":"publisher","first-page":"3540","DOI":"10.1158\/0008-5472.CAN-11-0096","volume":"71","author":"SF Ngiow","year":"2011","unstructured":"Ngiow, S. F. et al. Anti-TIM3 antibody promotes T cell IFN-gamma-mediated antitumor immunity and suppresses established tumors. Cancer Res. 71, 3540\u20133551 (2011).","journal-title":"Cancer Res"},{"key":"1251_CR21","first-page":"1904","volume":"123","author":"DB Johnson","year":"2017","unstructured":"Johnson, D. B., Sullivan, R. J. & Menzies, A. M. Immune checkpoint inhibitors in challenging populations. Cancer-Am. Cancer Soc. 123, 1904\u20131911 (2017).","journal-title":"Cancer-Am. Cancer Soc."},{"key":"1251_CR22","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1146\/annurev-immunol-031210-101400","volume":"29","author":"S Crotty","year":"2011","unstructured":"Crotty, S. Follicular helper CD4 Tcells (TFH). Annu. Rev. Immunol. 29, 621\u2013663 (2011).","journal-title":"Annu. Rev. Immunol."},{"key":"1251_CR23","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.coi.2011.08.003","volume":"23","author":"W Liao","year":"2011","unstructured":"Liao, W., Lin, J. X. & Leonard, W. J. IL-2 family cytokines: new insights into the complex roles of IL-2 as a broad regulator of T helper cell differentiation. Curr. Opin. Immunol. 23, 598\u2013604 (2011).","journal-title":"Curr. Opin. Immunol."},{"key":"1251_CR24","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1038\/2006","volume":"4","author":"MP Piccinni","year":"1998","unstructured":"Piccinni, M. P. et al. Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions. Nat. Med. 4, 1020\u20131024 (1998).","journal-title":"Nat. Med"},{"key":"1251_CR25","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.4049\/jimmunol.1302678","volume":"92","author":"L Xin","year":"2014","unstructured":"Xin, L. et al. Cutting edge: committed Th1 CD4+ T cell differentiation blocks pregnancy-induced Foxp3 expression with antigen-specific fetal loss. J. Immunol1 92, 2970\u20132974 (2014).","journal-title":"J. Immunol1"},{"key":"1251_CR26","doi-asserted-by":"publisher","first-page":"13645","DOI":"10.1073\/pnas.1511526112","volume":"112","author":"KM Bialas","year":"2015","unstructured":"Bialas, K. M. et al. Maternal CD4+ T cells protect against severe congenital cytomegalovirus disease in a novel nonhuman primate model of placental cytomegalovirus transmission. Proc. Natl Acad. Sci. USA 112, 13645\u201313650 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1251_CR27","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jri.2009.05.003","volume":"82","author":"T Tilburgs","year":"2009","unstructured":"Tilburgs, T. et al. Fetal-maternal HLA-C mismatch is associated with decidual T cell activation and induction of functional T regulatory cells. J. Reprod. Immunol. 82, 148\u2013157 (2009).","journal-title":"J. Reprod. Immunol."},{"key":"1251_CR28","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.humimm.2005.06.007","volume":"66","author":"MB Heemskerk","year":"2005","unstructured":"Heemskerk, M. B. et al. Allogeneic MHC class I molecules with numerous sequence differences do not elicit a CTL response. Hum. Immunol. 66, 969\u2013976 (2005).","journal-title":"Hum. Immunol."},{"key":"1251_CR29","doi-asserted-by":"publisher","first-page":"4751","DOI":"10.4049\/jimmunol.0803801","volume":"182","author":"WA Burgers","year":"2009","unstructured":"Burgers, W. A. et al. Association of HIV-specific and total CD8+ T memory phenotypes in subtype C HIV-1 infection with viral set point. J. Immunol. 182, 4751\u20134761 (2009).","journal-title":"J. Immunol."},{"key":"1251_CR30","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/j.1600-0897.2010.00852.x","volume":"63","author":"S Saito","year":"2010","unstructured":"Saito, S., Nakashima, A., Shima, T. & Ito, M. Th1\/Th2\/Th17 and regulatory T-cell paradigm in pregnancy. Am. J. Reprod. Immunol. 63, 601\u2013610 (2010).","journal-title":"Am. J. Reprod. Immunol."},{"key":"1251_CR31","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1093\/humrep\/dew019","volume":"31","author":"S Wang","year":"2016","unstructured":"Wang, S. et al. Programmed cell death-1 (PD-1) and T-cell immunoglobulin mucin-3 (Tim-3) regulate CD4+ T cells to induce type 2 helper T cell (Th2) bias at the maternal-fetal interface. Hum. Reprod. 31, 700\u2013711 (2016).","journal-title":"Hum. Reprod."},{"key":"1251_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2015.112","volume":"6","author":"SC Wang","year":"2015","unstructured":"Wang, S. C. et al. PD-1 and Tim-3 pathways are associated with regulatory CD8+ T-cell function in decidua and maintenance of normal pregnancy. Cell Death Dis. 6, e1738 (2015).","journal-title":"Cell Death Dis."},{"key":"1251_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/srep09013","volume":"5","author":"S Wang","year":"2015","unstructured":"Wang, S. et al. Tim-3 protects decidual stromal cells from toll-like receptor-mediated apoptosis and inflammatory reactions and promotes Th2 bias at the maternal-fetal interface. Sci. Rep. 5, 9013 (2015).","journal-title":"Sci. Rep."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1251-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1251-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1251-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T16:25:32Z","timestamp":1671207932000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-1251-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,8]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1]]}},"alternative-id":["1251"],"URL":"https:\/\/doi.org\/10.1038\/s41419-018-1251-0","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,8]]},"assertion":[{"value":"18 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"15"}}